Xtx Topco LTD Chemomab Therapeutics Ltd. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$1.09 - $2.44 $12,703 - $28,438	-11,655 Reduced 46.75%	13,274 $14,000
Q4 2024 Feb 13, 2025	BUY	$1.13 - $2.02 $10,967 - $19,606	9,706 Added 63.76%	24,929 $50,000
Q3 2024 Nov 14, 2024	BUY	$0.93 - $2.46 $146 - $386	157 Added 1.04%	15,223 $23,000
Q2 2024 Aug 12, 2024	BUY	$0.59 - $1.29 $8,888 - $19,435	15,066 New	15,066 $13,000
Q4 2023 Feb 13, 2024	BUY	$0.45 - $0.9 $13,071 - $26,142	29,047 New	29,047 $14,000

2.7M

Ticker CMMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,431,700
Market Cap $10.5M
Description
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.